IMMPACT:Initiative for Cell Mortality Programme Assessment.

Cell Death, Apoptosis, Oxidative stress, Caspase, BCL2

immpact-international

First-Line Therapy for Chronic Lymphocytic Leukemia: Bruton Tyrosine Kinase or BCL2 or Both?

Novel therapies largely have changed chemoimmunotherapy as optimum first-line therapy of persistent lymphocytic leukemia (CLL). Accredited novel therapies for CLL within the first-line setting embody Bruton tyrosine kinase inhibitors, ibrutinib and acalabrutinib, and the BCL2 inhibitor venetoclax. Every of those novel brokers has its personal distinctive attributes they usually haven’t been in contrast face to face in randomized trials. This overview summarizes the pivotal trials that led to the approval of novel brokers and compares the options of every agent to information therapy choices in treatment-naïve CLL. Ongoing research investigating combos of novel brokers within the first-line setting are also mentioned.

Community-based techniques pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia

T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological malignancy, and novel therapeutics are a lot wanted. Profiling affected person leukemia’ drug sensitivities ex vivo, we found that 44.4% of childhood and 16.7% of grownup T-ALL circumstances exquisitely reply to dasatinib. Making use of network-based techniques pharmacology analyses to look at sign circuitry, we recognized preTCR-LCK activation as the driving force of dasatinib sensitivity, and T-ALL-specific LCK dependency was confirmed in genome-wide CRISPR-Cas9 screens.
Dasatinib-sensitive T-ALLs exhibited excessive BCL-XL and low BCL2 exercise and venetoclax resistance. Discordant sensitivity of T-ALL to dasatinib and venetoclax is strongly correlated with T-cell differentiation, notably with the dynamic shift in LCK vs. BCL2 activation. Lastly, single-cell evaluation recognized leukemia heterogeneity in LCK and BCL2 signaling and T-cell maturation stage, in step with dasatinib response. In conclusion, our outcomes point out that developmental arrest in T-ALL drives differential activation of preTCR-LCK and BCL2 signaling on this leukemia, offering distinctive alternatives for focused remedy.

Blood concentrations of proapoptotic sFas and antiapoptotic Bcl2 and COVID-19 affected person mortality

Background: Cell dying by apoptosis is elevated in septic sufferers. Nonetheless, there are usually not information about circulating concentrations of sFas (proapoptotic protein of extrinsic pathway) and Bcl2 (antiapoptotic protein of intrinsic pathway) in COVID-19 sufferers. Thus, our goal examine was to find out whether or not exists an affiliation between serum concentrations of sFas and Bcl2 and COVID-19 affected person mortality.
Strategies: This observational and potential examine of COVID-19 sufferers was carried out in eight Intensive Care Items (ICU) from Canary Islands (Spain). Serum ranges of sFas and Bcl2 at ICU admission had been decided. Mortality at 30 days was the end-point examine.
Outcomes: Surviving sufferers (n=42) in comparison with non-surviving (n=11) had decrease APACHE-II (p<0.001), decrease SOFA (p=0.004), decrease serum sFas ranges (p=0.001) and better serum Bcl2 ranges (p<0.001). Logistic regression confirmed an affiliation between excessive serum sFas ranges and mortality after controlling for APACHE-II (OR=1.004; 95% CI=1.101-1.007; p=0.01) or SOFA (OR=1.003; 95% CI=1.101-1.106; p=0.004), and between low serum Bcl2 ranges and mortality after controlling for APACHE-II (OR=0.927; 95% CI=0.873-0.984; p=0.01) or SOFA (OR=0.949; 95% CI=0.913-0.987; p=0.01).
Conclusions: Thus, to the most effective of our data, that is the primary examine reporting blood ranges of sFas and Bcl2 in COVID-19 sufferers and its affiliation with mortality.
Key phrases: Bcl2; COVID-19: sufferers; mortality; sFas.
immpact-international
immpact-international

Galectin-Three immunolabelling correlates with BCL2 expression in canine cutaneous mast cell tumours

Mast cell tumour (MCT) is essentially the most frequent pores and skin neoplasm in canine. These tumours are characterised by variable behaviour and scientific presentation that make prognosis an essential and difficult process within the veterinary follow. Galectin-3 (Gal-3) is thought to affect a number of organic processes which are essential within the most cancers context and has been described as a prognostic marker for a number of human cancers.
  • The goal of the current work was to characterise Gal-Three immunolabelling in canine cutaneous MCTs and to research its worth as a prognostic marker for the illness. Thirty-four random circumstances of canine cutaneous MCT that had been surgically handled with broad margins had been included on this examine. Gal-Three expression was evaluated utilizing immunohistochemistry and the outcomes had been in contrast with the expression of apoptosis-related proteins, Ki67 index, histopathological grades, mortality as a result of illness and post-surgical survival.
  • Nearly all of the MCTs (65.8%) had been constructive for Gal-3. Gal-Three immunolabelling was variable among the many samples (2.7%-86.8% of the neoplastic cells). The protein was situated within the cytoplasm or within the cytoplasm and the nucleus. Gal-Three positivity was correlated with BCL2 expression (P < 0.001; r = 0.604), however not with Ki67 and BAX. No vital variations had been detected between histological grades or within the survival evaluation.
  • Gal-Three expression correlates with BCL2 expression in MCTs. Though an environment friendly marker for a number of human neoplasms, the outcomes offered herein counsel that Gal-Three immunolabelling just isn’t an impartial prognostic indicator for this illness.

Silica Nanoparticles Induce Hepatotoxicity by Triggering Oxidative Injury, Apoptosis, and Bax-Bcl2 Signaling Pathway

The rise within the utilization of silica nanoparticles (SiNPs) within the industrial and medical fields has raised considerations about their doable opposed results on human well being. The current examine aimed to research the potential opposed results of SiNPs at day by day doses of 25 and 100 mg/kg physique weight intraperitoneally (i.p.) for 28 consecutive days on markers of liver harm in grownup male rats. Outcomes revealed that SiNPs induced a marked enhance in serum markers of liver harm, together with lactate dehydrogenase (LDH), alanine aminotransferase (ALAT), and aspartate aminotransferase (ASAT).
SiNPs additionally induced an elevation of reactive oxygen species (ROS) manufacturing in liver, together with a rise in oxidative stress markers (NO, MDA, PCO, and H2O2), and a lower in antioxidant enzyme actions (CAT, SOD, and GPx). Quantitative real-time PCR confirmed that SiNPs additionally induced upregulation of pro-apoptotic gene expression (together with Bax, p53, Caspase-9/3) and downregulation of anti-apoptotic elements Bcl-2.
Furthermore, histopathological evaluation revealed that SiNPs induced hepatocyte alterations, which was accompanied by sinusoidal dilatation, Kupffer cell hyperplasia, and the presence of inflammatory cells within the liver. Taken collectively, these information confirmed that SiNPs set off hepatic harm by ROS-activated caspase signaling pathway, which performs a basic function in SiNP-induced apoptosis within the liver.

Recombinant Human Bcl-2-like Protein 11/BIML (N-6His)
CR24-1mg 1mg
EUR 2983.2
Description: Supplied as a 0.2 μm filtered solution of 20mM HEPES, 150mM NaCl, 10% glycerol, 2mM DTT, pH8.0

Recombinant Human Bcl-2-like Protein 11/BIML (N-6His)
CR24-500ug 500ug
EUR 1935.6
Description: Supplied as a 0.2 μm filtered solution of 20mM HEPES, 150mM NaCl, 10% glycerol, 2mM DTT, pH8.0

Recombinant Human Bcl-2-like Protein 11/BIML (N-6His)
CR24-50ug 50ug
EUR 595.2
Description: Supplied as a 0.2 μm filtered solution of 20mM HEPES, 150mM NaCl, 10% glycerol, 2mM DTT, pH8.0

Recombinant Human Bcl-2-like protein 11 Protein, His, Yeast-1mg
QP5712-ye-1mg 1mg
EUR 2262

Recombinant Human Bcl-2-like protein 11 Protein, His, Yeast-10ug
QP5712-ye-10ug 10ug
EUR 283.2

Recombinant Human Bcl-2-like protein 11 Protein, His, Yeast-50ug
QP5712-ye-50ug 50ug
EUR 358.8

Recombinant Human Bcl-2-like protein 11 Protein, His, Yeast-100ug
QP5712-ye-100ug 100ug
EUR 576

Recombinant Human Bcl-2-like protein 11 Protein, His, Yeast-200ug
QP5712-ye-200ug 200ug
EUR 892.8

Recombinant Human Bcl-2-like protein 11 Protein, His, Yeast-500ug
QP5712-ye-500ug 500ug
EUR 1447.2

BCL2L11 BCL2 Like 11 Human Recombinant Protein
PROTO43521 Regular: 10ug
EUR 380.4
Description: BCL2L11 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 162 amino acids (1-138 a.a) and having a molecular mass of 18.5kDa.;BCL2L11 is fused to a 24 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Recombinant Human Bcl-2-like protein 11 Protein, His-SUMO, E.coli-1mg
QP5712-ec-1mg 1mg
EUR 1958.4

Recombinant Human Bcl-2-like protein 11 Protein, His-SUMO, E.coli-10ug
QP5712-ec-10ug 10ug
EUR 240

Recombinant Human Bcl-2-like protein 11 Protein, His-SUMO, E.coli-50ug
QP5712-ec-50ug 50ug
EUR 315.6

Recombinant Human Bcl-2-like protein 11 Protein, His-SUMO, E.coli-100ug
QP5712-ec-100ug 100ug
EUR 489.6

Recombinant Human Bcl-2-like protein 11 Protein, His-SUMO, E.coli-200ug
QP5712-ec-200ug 200ug
EUR 760.8

Recombinant Human Bcl-2-like protein 11 Protein, His-SUMO, E.coli-500ug
QP5712-ec-500ug 500ug
EUR 1272

Recombinant Mouse Bcl-2 Protein, His, E.coli-1mg
QP5710-ec-1mg 1mg
EUR 2013.6

Recombinant Mouse Bcl-2 Protein, His, E.coli-10ug
QP5710-ec-10ug 10ug
EUR 186

Recombinant Mouse Bcl-2 Protein, His, E.coli-50ug
QP5710-ec-50ug 50ug
EUR 337.2

Recombinant Mouse Bcl-2 Protein, His, E.coli-100ug
QP5710-ec-100ug 100ug
EUR 501.6

Recombinant Mouse Bcl-2 Protein, His, E.coli-200ug
QP5710-ec-200ug 200ug
EUR 762

Recombinant Mouse Bcl-2 Protein, His, E.coli-500ug
QP5710-ec-500ug 500ug
EUR 1263.6

Mouse Bcl 2 like protein 11(BCL2L11) ELISA kit
E03B0766-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Mouse Bcl 2 like protein 11(BCL2L11) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse Bcl 2 like protein 11(BCL2L11) ELISA kit
E03B0766-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Mouse Bcl 2 like protein 11(BCL2L11) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse Bcl 2 like protein 11(BCL2L11) ELISA kit
E03B0766-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Mouse Bcl 2 like protein 11(BCL2L11) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse Bcl- 2- like protein 11, Bcl2l11 ELISA KIT
ELI-24063m 96 Tests
EUR 1038

BCL2L2 BCL2 Like 2 Human Recombinant Protein
PROTQ92843-1 Regular: 20ug
EUR 380.4
Description: Recombinant Human BCL2L2 produced in E.coli cells is a non-glycosylated, homodimeric protein containing 171 amino acid chain and having a molecular mass of 18.6kDa. The Human BCL2L2 is purified by proprietary chromatographic techniques.

Recombinant B-Cell CLL/Lymphoma 2 Like Protein 2 (Bcl2L2)
4-RPL251Ca01
  • EUR 640.39
  • EUR 295.20
  • EUR 2071.49
  • EUR 770.50
  • EUR 1420.99
  • EUR 504.00
  • EUR 4998.72
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Dog B-Cell CLL/Lymphoma 2 Like Protein 2 expressed in: E.coli

Recombinant B-Cell CLL/Lymphoma 2 Like Protein 2 (Bcl2L2)
4-RPL251Hu01
  • EUR 496.32
  • EUR 256.80
  • EUR 1531.20
  • EUR 590.40
  • EUR 1060.80
  • EUR 408.00
  • EUR 3648.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human B-Cell CLL/Lymphoma 2 Like Protein 2 expressed in: E.coli

Recombinant B-Cell CLL/Lymphoma 2 Like Protein 2 (Bcl2L2)
4-RPL251Mu01
  • EUR 582.34
  • EUR 279.60
  • EUR 1853.76
  • EUR 697.92
  • EUR 1275.84
  • EUR 465.60
  • EUR 4454.40
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Mouse B-Cell CLL/Lymphoma 2 Like Protein 2 expressed in: E.coli

Recombinant Human Bcl-2-like protein 15 Protein, GST, E.coli-1mg
QP7698-ec-1mg 1mg
EUR 2763.6

Recombinant Mouse Bcl XL Protein, Untagged, E.coli-1mg
QP11140-1mg 1mg
EUR 2230.8

Recombinant Human Bcl-2-like protein 15 Protein, GST, E.coli-10ug
QP7698-ec-10ug 10ug
EUR 326.4

Recombinant Human Bcl-2-like protein 15 Protein, GST, E.coli-50ug
QP7698-ec-50ug 50ug
EUR 434.4

Recombinant B-Cell CLL/Lymphoma 2 Like Protein (Bcl2L)
4-RPE582Hu01
  • EUR 442.56
  • EUR 242.40
  • EUR 1329.60
  • EUR 523.20
  • EUR 926.40
  • EUR 372.00
  • EUR 3144.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human B-Cell CLL/Lymphoma 2 Like Protein expressed in: E.coli

Recombinant B-Cell CLL/Lymphoma 2 Like Protein (Bcl2L)
4-RPE582Mu01
  • EUR 421.06
  • EUR 236.40
  • EUR 1248.96
  • EUR 496.32
  • EUR 872.64
  • EUR 357.60
  • EUR 2942.40
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Mouse B-Cell CLL/Lymphoma 2 Like Protein expressed in: E.coli

Recombinant B-Cell CLL/Lymphoma 2 Like Protein (Bcl2L)
4-RPE582Ra01
  • EUR 528.58
  • EUR 265.20
  • EUR 1652.16
  • EUR 630.72
  • EUR 1141.44
  • EUR 429.60
  • EUR 3950.40
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Rat B-Cell CLL/Lymphoma 2 Like Protein expressed in: E.coli

Recombinant Human Bcl-2-like protein 15 Protein, GST, E.coli-100ug
QP7698-ec-100ug 100ug
EUR 685.2

Recombinant Human Bcl-2-like protein 15 Protein, GST, E.coli-200ug
QP7698-ec-200ug 200ug
EUR 1077.6

Recombinant Human Bcl-2-like protein 15 Protein, GST, E.coli-500ug
QP7698-ec-500ug 500ug
EUR 1816.8

Recombinant Mouse Bcl XL Protein, Untagged, E.coli-10ug
QP11140-10ug 10ug
EUR 186

Recombinant Mouse Bcl XL Protein, Untagged, E.coli-50ug
QP11140-50ug 50ug
EUR 241.2

Bcl-2 Related Protein A1 Recombinant Protein
91-086 0.05 mg
EUR 569.4
Description: Bcl-2-Related Protein A1 (BCL2A1) is a member of of the BCL-2 protein family which act as anti- and pro-apoptotic regulators that are involved in a wide variety of cellular activities such as embryonic development, homeostasis and tumorigenesis. BCL2A1 is a cytoplasm protein and interacts directly with BAK1, BID, BMF and BBC3. BCL2A1 is induced by phorbol ester and inflammatory cytokines, such as TNF or IL1B/interleukin-1 beta, but not by growth factors. BCL2A1 is invovled in the response of hemopoietic cells to external signals and in maintaining endothelial survival during infection.

Recombinant NEL Like Protein 2 (NELL2)
4-RPL934Hu01
  • EUR 580.19
  • EUR 278.40
  • EUR 1845.70
  • EUR 695.23
  • EUR 1270.46
  • EUR 463.20
  • EUR 4434.24
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human NEL Like Protein 2 expressed in: E.coli

Recombinant mouse Complement component receptor 1-like protein
P2548 100ug Ask for price
Description: Recombinant protein for mouse Complement component receptor 1-like protein

BCL2L2 Human, BCL2 Like 2 Human Recombinant Protein, His Tag
PROTQ92843 Regular: 25ug
EUR 380.4
Description: BCL2L2 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 192 amino acids (1-172 a.a.) and having a molecular weight of 20.9kDa.;The BCL2L2 is fused to a 20 a.a His-Tag at N-terminus and purified by proprietary chromatographic techniques.

Recombinant RAD54 Like Protein 2 (RAD54L2)
4-RPR945Hu01
  • EUR 560.83
  • EUR 273.60
  • EUR 1773.12
  • EUR 671.04
  • EUR 1222.08
  • EUR 451.20
  • EUR 4252.80
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human RAD54 Like Protein 2 expressed in: E.coli

Chitinase 3-Like Protein 2 Recombinant Protein
91-523 0.05 mg
EUR 651.3
Description: Chitinase 3-Like Protein 2 (CHI3L2) is a 39 kDa secreted glycoprotein which belongs to the glycosyl hydrolase 18 family and the most closely related to human cartilage glycoprotein 39, which promotes the growth of human synovial cells as well as skin and fetal lung fibroblasts. Highest expression of CHI3L2 is in chondrocytes, followed by synoviocytes, lung and heart. It is not detected in spleen, pancreas, and liver. CHI3L2 may also be expressed in developing brain and placenta. Increased levels of CHI3L2 have been demonstrated in synovial fluids of patients with rheumatoid or osteoarthritis as well as in some other pathologies and in malignant tumors, particularly in glioblastomas. CHI3L2 may bind glycan structure with high affinity, but not heparin. It has has no chitotriosidase activity, but is likely to bind some type of glycan.

Recombinant Chordin Like Protein 2 (CHRDL2)
4-RPF626Mu01
  • EUR 601.69
  • EUR 284.40
  • EUR 1926.34
  • EUR 722.11
  • EUR 1324.22
  • EUR 477.60
  • EUR 4635.84
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Mouse Chordin Like Protein 2 expressed in: E.coli

Recombinant Human BAX/Bcl-2-Like Protein 4/BCL2L4 (N, C-6His)
CF02-10ug 10ug
EUR 242.4
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4.

Recombinant Human BAX/Bcl-2-Like Protein 4/BCL2L4 (N, C-6His)
CF02-1mg 1mg
EUR 2983.2
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4.

Recombinant Human BAX/Bcl-2-Like Protein 4/BCL2L4 (N, C-6His)
CF02-500ug 500ug
EUR 2106
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4.

Recombinant Human BAX/Bcl-2-Like Protein 4/BCL2L4 (N, C-6His)
CF02-50ug 50ug
EUR 595.2
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4.

Recombinant Fibrinogen Like Protein 2 (FGL2)
4-RPA512Hu01
  • EUR 550.08
  • EUR 271.20
  • EUR 1732.80
  • EUR 657.60
  • EUR 1195.20
  • EUR 444.00
  • EUR 4152.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Fibrinogen Like Protein 2 expressed in: E.coli

Recombinant Fibrinogen Like Protein 2 (FGL2)
4-RPA512Mu01
  • EUR 578.04
  • EUR 278.40
  • EUR 1837.63
  • EUR 692.54
  • EUR 1265.09
  • EUR 462.00
  • EUR 4414.08
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Mouse Fibrinogen Like Protein 2 expressed in: E.coli

Recombinant Fibrinogen Like Protein 2 (FGL2)
4-RPA512Ra01
  • EUR 601.69
  • EUR 284.40
  • EUR 1926.34
  • EUR 722.11
  • EUR 1324.22
  • EUR 477.60
  • EUR 4635.84
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Rat Fibrinogen Like Protein 2 expressed in: E.coli

BCL2L1 BCL2-Like 1 Recombinant Protein Mouse
PROTQ64373 Regular: 20ug
EUR 380.4
Description: BCL2L1 Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 232 amino acids (1-209 a.a) and having a molecular mass of 25.8kDa. BCL2L1 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

BCL2L10 BCL2 Like 10 Human Recombinant Protein
PROTQ9HD36 Regular: 20ug
EUR 380.4
Description: BCL2L10 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 195 amino acids (1-172 a.a.) and having a molecular mass of 21.8kDa.;BCL2L10 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Bcl-xL Recombinant Protein
91-087 0.05 mg
EUR 651.3
Description: Bcl-2-Like Protein 1 (BCL2L1) is a member of the Bcl-2 family. BCL2L1 is expressed at high levels in cells that undergo a high rate of turnover, such as developing lymphocytes. BCL2L1 is a mitochondrial membrane protein. BCL2L1 contains four motifs, BH1, BH2 and BH4. The BH4 motif is required for anti-apoptotic activity. The BH1 and BH2 motifs are required for both heterodimerization with other Bcl-2 family members and for repression of cell death. BCL2L1 regulates cell death by blocking the voltage-dependent anion channnel (VDAC) and preventing the release of the caspase activator, CYC1, from the mitochondrial membrane. In addition, BCL2L1 promotes apoptosis.

IL-11 Interleukin-11 Mouse Recombinant Protein
PROTP47873 Regular: 10ug
EUR 380.4
Description: Interleukin-11 Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 179 amino acids and having a molecular mass of 19.1kDa. ;The Mouse IL-11 is purified by proprietary chromatographic techniques.

Recombinant Synaptotagmin Like Protein 2 (SYTL2)
4-RPH069Hu01
  • EUR 580.19
  • EUR 278.40
  • EUR 1845.70
  • EUR 695.23
  • EUR 1270.46
  • EUR 463.20
  • EUR 4434.24
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Synaptotagmin Like Protein 2 expressed in: E.coli

Recombinant Mouse Stromal cell-derived factor 2-like protein 1, His, Yeast-1mg
QP9916-ye-1mg 1mg
EUR 2763.6

Recombinant Angiopoietin Like Protein 2 (ANGPTL2)
4-RPB919Hu01
  • EUR 528.58
  • EUR 265.20
  • EUR 1652.16
  • EUR 630.72
  • EUR 1141.44
  • EUR 429.60
  • EUR 3950.40
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Angiopoietin Like Protein 2 expressed in: E.coli

Recombinant Angiopoietin Like Protein 2 (ANGPTL2)
4-RPB919Mu01
  • EUR 582.34
  • EUR 279.60
  • EUR 1853.76
  • EUR 697.92
  • EUR 1275.84
  • EUR 465.60
  • EUR 4454.40
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Mouse Angiopoietin Like Protein 2 expressed in: E.coli

Recombinant Angiopoietin Like Protein 2 (ANGPTL2)
4-RPB919Ra01
  • EUR 642.55
  • EUR 295.20
  • EUR 2079.55
  • EUR 773.18
  • EUR 1426.37
  • EUR 505.20
  • EUR 5018.88
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Rat Angiopoietin Like Protein 2 expressed in: E.coli

Recombinant Angiopoietin Like Protein 2 (ANGPTL2)
4-RPB919Ra02
  • EUR 642.55
  • EUR 295.20
  • EUR 2079.55
  • EUR 773.18
  • EUR 1426.37
  • EUR 505.20
  • EUR 5018.88
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Rat Angiopoietin Like Protein 2 expressed in: E.coli

Recombinant Mouse Stromal cell-derived factor 2-like protein 1, His, Yeast-100ug
QP9916-ye-100ug 100ug
EUR 685.2

Recombinant Mouse Stromal cell-derived factor 2-like protein 1, His, Yeast-10ug
QP9916-ye-10ug 10ug
EUR 326.4

Recombinant Mouse Stromal cell-derived factor 2-like protein 1, His, Yeast-200ug
QP9916-ye-200ug 200ug
EUR 1077.6

Recombinant Mouse Stromal cell-derived factor 2-like protein 1, His, Yeast-500ug
QP9916-ye-500ug 500ug
EUR 1806

Recombinant Mouse Stromal cell-derived factor 2-like protein 1, His, Yeast-50ug
QP9916-ye-50ug 50ug
EUR 424.8

Mouse Bcl 2 like protein 2(BCL2L2) ELISA kit
E03B0769-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Mouse Bcl 2 like protein 2(BCL2L2) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse Bcl 2 like protein 2(BCL2L2) ELISA kit
E03B0769-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Mouse Bcl 2 like protein 2(BCL2L2) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse Bcl 2 like protein 2(BCL2L2) ELISA kit
E03B0769-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Mouse Bcl 2 like protein 2(BCL2L2) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse Bcl- 2- like protein 2, Bcl2l2 ELISA KIT
ELI-11430m 96 Tests
EUR 1038

Recombinant Chitinase 3 Like Protein 2 (CHI3L2)
4-RPJ376Hu01
  • EUR 571.58
  • EUR 276.00
  • EUR 1813.44
  • EUR 684.48
  • EUR 1248.96
  • EUR 458.40
  • EUR 4353.60
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Chitinase 3 Like Protein 2 expressed in: E.coli

Recombinant Lysyl Oxidase Like Protein 2 (LOXL2)
4-RPF552Hu01
  • EUR 657.60
  • EUR 300.00
  • EUR 2136.00
  • EUR 792.00
  • EUR 1464.00
  • EUR 516.00
  • EUR 5160.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Lysyl Oxidase Like Protein 2 expressed in: E.coli
immpact-international
immpact-international